These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2838623)

  • 1. Human placental LHRH receptor: agonist and antagonist labeling produces differences in the size of the non-denatured, solubilized receptor.
    Escher E; Mackiewicz Z; Lagacé G; Lehoux JG; Gallo-Payet N; Bellabarba D; Bélisle S
    J Recept Res; 1988; 8(1-4):391-405. PubMed ID: 2838623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human placental gonadotrophin-releasing hormone (GnRH) binding sites: I. Characterization, properties and ligand specificity.
    Bramley TA; McPhie CA; Menzies GS
    Placenta; 1992; 13(6):555-81. PubMed ID: 1338344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubilization and characterization of the rat pituitary gonadotrophin-releasing hormone receptor.
    Iwashita M; Hirota K; Izumi SI; Chen HC; Catt KJ
    J Mol Endocrinol; 1988 Nov; 1(3):187-96. PubMed ID: 2855595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct effects of luteinizing hormone-releasing hormone agonists and antagonists on MCF-7 mammary cancer cells.
    Segal-Abramson T; Kitroser H; Levy J; Schally AV; Sharoni Y
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2336-9. PubMed ID: 1312718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salmon GnRH and its analogues bind the human placental receptor.
    Siler-Khodr TM; Grayson M
    J Soc Gynecol Investig; 2001; 8(4):233-8. PubMed ID: 11525899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photoaffinity labeling of pituitary GnRH receptors: significance of the position of photolabel on the ligand.
    Nikolics K; Szönyi E; Ramachandran J
    Biochemistry; 1988 Mar; 27(5):1425-32. PubMed ID: 2835092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solubilization and purification of rat pituitary gonadotropin-releasing hormone receptor.
    Hazum E; Schvartz I; Waksman Y; Keinan D
    J Biol Chem; 1986 Oct; 261(28):13043-8. PubMed ID: 3020021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prolonged action of the LHRH agonist buserelin (HOE 766) may be due to prolonged binding to the LHRH receptor.
    Koiter TR; Denef C; Andries M; Moes H; Schuiling GA
    Life Sci; 1986 Aug; 39(5):443-52. PubMed ID: 3016440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential orientation of a GnRH agonist and antagonist in the pituitary GnRH receptor.
    Janovick JA; Haviv F; Fitzpatrick TD; Conn PM
    Endocrinology; 1993 Aug; 133(2):942-5. PubMed ID: 8393780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photoaffinity labeling of luteinizing hormone releasing hormone receptor of rat pituitary membrane preparations.
    Hazum E
    Endocrinology; 1981 Oct; 109(4):1281-3. PubMed ID: 6269841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteinizing hormone-releasing hormone-binding sites in the rat thymus: characteristics and biological function.
    Marchetti B; Guarcello V; Morale MC; Bartoloni G; Farinella Z; Cordaro S; Scapagnini U
    Endocrinology; 1989 Aug; 125(2):1025-36. PubMed ID: 2546732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of different agonists and antagonists of luteinizing hormone-releasing hormone for receptor-binding ability to rat pituitary and human breast cancer membranes.
    Fekete M; Bajusz S; Groot K; Csernus VJ; Schally AV
    Endocrinology; 1989 Feb; 124(2):946-55. PubMed ID: 2536323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a gonadotropin-releasing hormone receptor site in term placenta and chorionic villi.
    Iwashita M; Evans MI; Catt KJ
    J Clin Endocrinol Metab; 1986 Jan; 62(1):127-33. PubMed ID: 2999176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of gonadotropin-releasing hormone receptors.
    Hazum E
    Methods Enzymol; 1990; 184():285-92. PubMed ID: 2167426
    [No Abstract]   [Full Text] [Related]  

  • 15. Photoaffinity labelling of gonadotropin releasing hormone binding sites in human epithelial ovarian carcinomata.
    Pahwa GS; Vollmer G; Knuppen R; Emons G
    Biochem Biophys Res Commun; 1989 Jun; 161(3):1086-92. PubMed ID: 2545195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human placental gonadotrophin-releasing hormone (GnRH) binding sites: II. Comparison of binding and inactivation of 125I-labelled GnRH agonist to subcellular fractions following density gradient centrifugation.
    Menzies GS; Bramley TA
    Placenta; 1992; 13(6):583-95. PubMed ID: 1338345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human placental GnRH-like factors: parallel displacement in GnRH immuno- and receptor-binding assays can be caused by degradation of radiolabelled GnRH tracers.
    Bramley TA; Boyle HP; Menzies GS
    Mol Hum Reprod; 1999 Dec; 5(12):1095-106. PubMed ID: 10587363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotropin-releasing hormone specific binding sites in uterine leiomyomata.
    Wiznitzer A; Marbach M; Hazum E; Insler V; Sharoni Y; Levy J
    Biochem Biophys Res Commun; 1988 May; 152(3):1326-31. PubMed ID: 2837183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary-testicular function is suppressed by an LHRH antagonist but not by an LHRH agonist in the marmoset monkey.
    Lunn SF; Dixson AF; Sandow J; Fraser HM
    J Endocrinol; 1990 May; 125(2):233-9. PubMed ID: 2165119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptors for luteinizing hormone-releasing hormone (LHRH) in Dunning R3327 prostate cancers and rat anterior pituitaries after treatment with a sustained delivery system of LHRH antagonist SB-75.
    Srkalovic G; Bokser L; Radulovic S; Korkut E; Schally AV
    Endocrinology; 1990 Dec; 127(6):3052-60. PubMed ID: 2174343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.